Bupivacaine Hydrochloride

CHEMBL1200396 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
324.9 g/mol
LogP
Phase
4

The hydrochloride salt form of bupivacaine, the most commonly used formulation of this long-acting local anesthetic. It is injected to block pain in specific regions of the body during and after surgical procedures, including labor. Its cardiac toxicity risk demands careful attention to total dose and accidental intravascular injection.

Peso Molecular

324,9000 g/mol

TPSA

32,30 Ų

Áreas Terapêuticas

Mecanismo de Ação

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl

InChI

InChI=1S/C18H28N2O.ClH/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H

Molecular Formula

C18H29ClN2O

HBD / HBA

2 / 2

Ligações Rotacionáveis

5

Átomos Pesados

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

The hydrochloride salt form of bupivacaine, the most commonly used formulation of this long-acting local anesthetic. It is injected to block pain in specific regions of the body during and after surgical procedures, including labor. Its cardiac toxicity risk demands careful attention to total dose and accidental intravascular injection.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Bupivacaine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200396. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 64737. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.